期刊
FERTILITY AND STERILITY
卷 96, 期 2, 页码 277-285出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2011.06.030
关键词
Oocyte; vitrification; cryopreservation; slow freezing; fertility preservation; ongoing pregnancy rate; meta-analysis
Objective: To perform a systematic review of the literature to identify randomized controlled trials assessing the efficacy of oocyte vitrification in terms of oocyte survival, fertilization, embryo development, and pregnancy rates. Design: Systematic review and meta-analysis of randomized controlled trials. Setting: Private university-affiliated IVF center, university-based hospital. Patient(s): Patients recruited in randomized controlled trials considering oocyte vitrification as one of the experimental arms and slow freezing or fresh oocytes control as the other. Intervention(s): Vitrification of human oocytes vs. slow freezing or fresh oocytes. Main Outcome Measure(s): Ongoing pregnancy rate; secondary outcomes were clinical pregnancy rate, implantation rate, embryo development, fertilization rate, and oocyte survival. Result(s): Five eligible studies were finally included. They involved 4,282 vitrified oocytes, 3,524 fresh oocytes, and 361 slow-frozen oocytes between 2005 and 2009. The rates of ongoing pregnancy, top-quality embryo, embryo cleavage, and fertilization did not differ between the vitrification and the fresh oocyte groups. The oocyte survival rate was higher in vitrified vs. slow-frozen oocytes (odds ratio [ OR] 2.46, 95% confidence interval [CI] 1.82-3.32), although heterogeneity between studies was observed. The fertilization rate was higher in vitrified vs. slow-frozen oocytes (OR 1.50, 95% CI 1.07-2.11). Vitrification also resulted in a higher rate top-quality embryo (22.4% vs. 8.0%, OR 3.32, 95% CI 1.37-8.02) and embryo cleavage rate (day 2: 64.6% vs. 47.7%, OR 2.00, 95% CI 1.33-3.00; day 3: 53.0% vs. 33.3%, OR 2.25, 95% CI 1.32-3.85) as compared with slow freezing. Conclusion(s): Vitrification is an efficient method to preserve oocytes, although more large controlled clinical trials are needed to strengthen this conclusion. (Fertil Steril (R) 2011; 96: 277-85. (C) 2011 by American Society for Reproductive Medicine.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据